Julie L. Gerberding's Net Worth
$28.1 Million
Who is Julie L. Gerberding?
Julie L. Gerberding has an estimated net worth of $28.1 Million. This is based on reported shares across multiple companies, which include CERNER CORP /MO/, Merck & Co., Inc., AfterNext HealthTech Acquisition Corp., and HilleVax, Inc..
SEC CIK
Julie L. Gerberding's CIK is 0001628884
Past Insider Trading and Trends
2021 was Julie L. Gerberding's most active year for acquiring shares with 7 total transactions. Julie L. Gerberding's most active month to acquire stocks was the month of April. 2016 was Julie L. Gerberding's most active year for disposing of shares, totalling 6 transactions. Julie L. Gerberding's most active month to dispose stocks was the month of October. 2018 saw Julie L. Gerberding paying a total of $2,476,272.88 for 78,657 shares, this is the most they've acquired in one year. In 2020 Julie L. Gerberding cashed out on 239,017 shares for a total of $12,021,841.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CERNER CORP /MO/ No price found
InvestorJulie L. Gerberding used to own units in Common Stock but no longer holds any shares there. In the year 2017 Julie L. Gerberding filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -15.03K |
$95.00 | -$1,428,040.00 |
0
|
Jun 7
| |||
Form 4
| +26.92% | 3.19K |
—
|
—
| 15.03K |
May 19
| |||
Form 4
| +45.72% | 3.72K |
—
|
—
| 11.84K |
May 22
| |||
Form 4
| -49.38% | -7.93K |
$71.82 | -$569,388.96 | 8.13K |
Aug 22
| |||
Form 4
| +28.45% | 3.56K |
—
|
—
| 16.06K |
May 30
| |||
Form 4
| +48.81% | 4.1K |
—
|
—
| 12.5K |
May 18
| |||
Form 4
| +86.67% | 3.9K |
—
|
—
| 8.4K |
May 24
| |||
Form 4
|
∞
| 4.5K |
—
|
—
| 4.5K |
Mar 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Merck & Co., Inc. (MRK) Snapshot price: $117.36
EVP, Chief Patient OfficerJulie L. Gerberding owns 48,712.138 units of Common Stock which is worth $5,716,856.52. In the year 2018 Julie L. Gerberding filed a total of 25 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.39% | 9.55K |
$73.51 | $702,020.50 | 48.71K |
Feb 24
| |||
Form 4
|
—
|
0
|
$87.91 | -$8,462,681.74 | 39.16K |
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +47.35% | 12.59K |
$72.62 | $913,922.70 | 39.16K |
Feb 26
| |||
Form 4
| -40.61% | -18.17K |
$80.00 | -$2,902,976.29 | 26.58K |
Scheduled
|
Jul 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +19.90% | 7.37K |
$76.56 | $564,323.76 | 44.41K |
Feb 28
| |||
Form 4
| -34.52% | -19.52K |
$89.34 | -$9,118,864.98 | 37.04K |
Scheduled
|
Jan 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| +18.79% | 8.75K |
$80.38 | $703,083.86 | 55.29K |
Feb 25
| |||
Form 4
|
—
|
0
|
$64.91 | -$740,947.84 | 46.26K |
Nov 7
| |||
Form 4
| -17.91% | -9.97K |
$59.66 | -$594,963.42 | 45.72K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +19.61% | 9.06K |
$54.72 | $495,872.64 | 55.28K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
| +4.65% | 2.01K |
$62.38 | -$67,245.64 | 45.34K |
May 2
| |||
Form 4
| +9.42% | 3.71K |
$65.85 | $244,105.95 | 43.06K |
Feb 27
| |||
Form 4
|
—
|
0
|
$50.78 | -$1,581,384.31 | 39.12K |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
| +6.73% | 2.44K |
$54.09 | -$84,704.94 | 38.65K |
May 6
| |||
Form 4
| +10.36% | 3.38K |
$50.77 | $171,450.29 | 35.99K |
Feb 22
| |||
Form 4
| +32.47% | 7.84K |
$48.14 | -$709,553.30 | 31.99K |
May 8
| |||
Form 4
| +12.09% | 2.6K |
$59.86 | -$72,670.04 | 24.15K |
May 1 - May 2
| |||
Form 4
| +14.68% | 2.74K |
$58.30 | $159,508.80 | 21.37K |
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AfterNext HealthTech Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HilleVax, Inc. (HLVX) Snapshot price: $1.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||